Dividend Stock Wednesday: Abbott Labs (ABT-NYSE)
This is an analysis completed by The Dividend Guy. It is not to be used as investment advice or a recommendation to buy, hold, or sell any stocks discussed. Please ensure you complete your own analysis. As a holder of Pfizer, I am not in the market for another pharmaceutical company. However, with the strong dividend growth that Abbott Labs has seen in the past 10 years, I would be tempted if the price was right. Let's have a look at ABT to see how it shapes up in the fundamentals and …
Continue Reading about Dividend Stock Wednesday: Abbott Labs (ABT-NYSE)